1. Home
  2. CNTB vs PXLW Comparison

CNTB vs PXLW Comparison

Compare CNTB & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • PXLW
  • Stock Information
  • Founded
  • CNTB 2012
  • PXLW 1997
  • Country
  • CNTB United States
  • PXLW United States
  • Employees
  • CNTB N/A
  • PXLW N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • PXLW Semiconductors
  • Sector
  • CNTB Health Care
  • PXLW Technology
  • Exchange
  • CNTB Nasdaq
  • PXLW Nasdaq
  • Market Cap
  • CNTB 54.4M
  • PXLW 64.2M
  • IPO Year
  • CNTB 2021
  • PXLW 2000
  • Fundamental
  • Price
  • CNTB $2.00
  • PXLW $10.78
  • Analyst Decision
  • CNTB Strong Buy
  • PXLW Strong Buy
  • Analyst Count
  • CNTB 2
  • PXLW 2
  • Target Price
  • CNTB $7.50
  • PXLW $15.00
  • AVG Volume (30 Days)
  • CNTB 280.7K
  • PXLW 111.3K
  • Earning Date
  • CNTB 09-04-2025
  • PXLW 08-12-2025
  • Dividend Yield
  • CNTB N/A
  • PXLW N/A
  • EPS Growth
  • CNTB N/A
  • PXLW N/A
  • EPS
  • CNTB N/A
  • PXLW N/A
  • Revenue
  • CNTB $26,033,000.00
  • PXLW $34,246,000.00
  • Revenue This Year
  • CNTB N/A
  • PXLW $5.21
  • Revenue Next Year
  • CNTB N/A
  • PXLW $35.68
  • P/E Ratio
  • CNTB N/A
  • PXLW N/A
  • Revenue Growth
  • CNTB N/A
  • PXLW N/A
  • 52 Week Low
  • CNTB $0.51
  • PXLW $4.67
  • 52 Week High
  • CNTB $2.86
  • PXLW $15.03
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 59.15
  • PXLW 56.81
  • Support Level
  • CNTB $1.70
  • PXLW $9.70
  • Resistance Level
  • CNTB $2.45
  • PXLW $12.47
  • Average True Range (ATR)
  • CNTB 0.36
  • PXLW 1.51
  • MACD
  • CNTB -0.02
  • PXLW 0.01
  • Stochastic Oscillator
  • CNTB 42.51
  • PXLW 39.63

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

Share on Social Networks: